kabutan

RIKEN VITAMIN, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 22%

Thu Feb 12, 2026 4:00 pm JST Earnings

4526 RIKEN VITAMIN CO.,LTD. 【J-GAAP】

Earnings Report

RIKEN VITAMIN CO.,LTD. <4526> [TSE Prime] announced its financial results after the market closed on February 12th (16:00). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) decreased 22.3% from the same period last year to 6.40 billion yen.

In addition, the full-year forecast for consolidated ordinary profit has decreased 22.2%, from the previous forecast of 9.00 billion yen to 7.00 billion yen (compared to 9.41 billion yen in the previous period), leading to an increase in the profit decline rate from 4.4% to 25.7%.

Based on the full-year plan announced by the company after the downward revision, our estimate of the consolidated ordinary profit for the October to March period (second half) has decreased 43.2%, from the previous forecast of 4.63 billion yen to 2.63 billion yen (compared to 4.63 billion yen in the same period of the previous year). This changes the outlook from an anticipated profit increase to a projection of a 43.2% decrease in profit.

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit dropped to 2.03 billion yen, a 41.1% decrease compared to the same period last year. The operating profit margin significantly dropped from 11.4% in the same period last year to 6.4%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2023 69,058 7,660 8,396 6,080 185.3 81.5 Feb 9, 2024 J-GAAP
Apr - Dec, 2024 72,852 7,544 8,241 5,834 192.2 87.5 Feb 14, 2025 J-GAAP
Apr - Dec, 2025 72,503 5,716 6,403 5,949 200.8 91.5 Feb 12, 2026 J-GAAP
YoY -0.5% -24.2% -22.3% +2.0% +4.5%

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2025 Prev 52,735 4,409 4,632 4,839 165.2 55 Nov 13, 2025 J-GAAP
Oct - Mar, 2025 New 48,735 2,109 2,632 3,139 107.2 55 Feb 12, 2026 J-GAAP
Revision Rate -7.6% -52.2% -43.2% -35.1% -35.1%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Prev 100,000 8,500 9,000 8,200 280.0 110 May 14, 2025 J-GAAP
Mar, 2026 New 96,000 6,200 7,000 6,500 221.9 110 Feb 12, 2026 J-GAAP
Revision Rate -4.0% -27.1% -22.2% -20.7% -20.7%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 48,433 4,098 4,631 6,133 202.6 53.50 May 14, 2025 J-GAAP
Oct - Mar, 2025 Guidance 48,735 2,109 2,632 3,139 107.2 55 Feb 12, 2026 J-GAAP
YoY +0.6% -48.5% -43.2% -48.8% -47.1%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 91,484 9,371 10,296 8,755 268.4 81 May 10, 2024 J-GAAP
Mar, 2025 95,582 8,724 9,417 9,388 310.1 94 May 14, 2025 J-GAAP
Mar, 2026 Guidance 96,000 6,200 7,000 6,500 221.9 110 Feb 12, 2026 J-GAAP
YoY +0.4% -28.9% -25.7% -30.8% -28.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 25,703 2,918 3,455 2,579 85.0 11.4 Feb 14, 2025 J-GAAP
Jan - Mar, 2025 22,730 1,180 1,176 3,554 117.4 5.2 May 14, 2025 J-GAAP
Apr - Jun, 2025 23,257 2,365 2,531 1,825 61.2 10.2 Aug 8, 2025 J-GAAP
Jul - Sep, 2025 24,008 1,726 1,837 1,536 51.7 7.2 Nov 13, 2025 J-GAAP
Oct - Dec, 2025 25,238 1,625 2,035 2,588 87.3 6.4 Feb 12, 2026 J-GAAP
YoY -1.8% -44.3% -41.1% +0.3% +2.8%

Related Articles